Reata Pharmaceuticals (RETA) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Reata Pharmaceuticals (RETA) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (06:52)

Sector: Healthcare

The share price of Reata Pharmaceuticals, Inc. (RETA) now

Latest session on the 26th of September for
Reata Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 172.36 /  High: 172.36 /  Low: 172.36
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Reata Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Reata Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Reata Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Reata Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Reata Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Reata Pharmaceuticals stock? When should I record a loss on Reata Pharmaceuticals stock? What are analysts' forecasts for Reata Pharmaceuticals stock? What is the future of Reata Pharmaceuticals stock? We forecast Reata Pharmaceuticals stock performance using neural networks based on historical data on Reata Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Reata Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Reata Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Reata Pharmaceuticals stock

The chart below shows the historical price of Reata Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Reata Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Reata Pharmaceuticals, Inc., a clinical biopharmaceutical company, is developing new therapies for patients with serious or life-threatening illnesses by targeting molecular pathways that regulate cellular metabolism and inflammation.

Reata Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 07 177.92 174.98 182.19 4.12
Dec 08 180.50 176.53 184.74 4.65
Dec 09 181.22 175.33 183.58 4.70
Dec 10 173.52 170.22 177.60 4.33
Dec 11 172.13 165.50 176.69 6.76
Dec 12 168.26 161.86 170.70 5.46
Dec 13 170.53 164.82 174.02 5.59
Dec 14 174.45 168.26 176.54 4.92
Dec 15 165.73 161.92 168.55 4.09
Dec 16 163.33 161.61 166.27 2.88
Dec 17 155.73 150.75 158.61 5.22
Dec 18 159.62 157.39 165.53 5.17
Dec 19 167.37 162.01 172.72 6.61
Dec 20 167.78 165.02 172.99 4.83
Dec 21 165.52 161.96 170.15 5.06
Dec 22 165.19 160.98 171.55 6.57
Dec 23 161.22 155.18 163.32 5.25
Dec 24 158.97 155.47 163.50 5.16
Dec 25 151.81 149.08 154.24 3.46
Dec 26 149.54 145.57 153.65 5.55
Dec 27 148.79 145.81 154.37 5.87
Dec 28 151.91 150.39 156.77 4.24
Dec 29 149.86 144.54 153.83 6.43
Dec 30 149.19 145.98 151.28 3.63
Dec 31 153.81 148.81 159.66 7.29
Jan 01 151.66 149.69 154.16 2.99
Jan 02 149.01 146.77 154.07 4.98
Jan 03 142.23 138.31 145.71 5.35
Jan 04 143.15 138.00 145.37 5.34
Jan 05 143.87 140.56 146.46 4.20

Reata Pharmaceuticals Daily Price Targets


Reata Pharmaceuticals Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $177.92.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 3.955%.
Pessimistic target level: 174.98
Optimistic target level: 182.19

Reata Pharmaceuticals Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $180.50.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.446%.
Pessimistic target level: 176.53
Optimistic target level: 184.74

Reata Pharmaceuticals Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $181.22.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.492%.
Pessimistic target level: 175.33
Optimistic target level: 183.58

Reata Pharmaceuticals Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $173.52.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.153%.
Pessimistic target level: 170.22
Optimistic target level: 177.60

Reata Pharmaceuticals Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $172.13.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 6.332%.
Pessimistic target level: 165.50
Optimistic target level: 176.69

Reata Pharmaceuticals Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $168.26.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 5.175%.
Pessimistic target level: 161.86
Optimistic target level: 170.70

RETA (RETA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 202.70 193.78 218.10 11.15

Reata Pharmaceuticals forecast for this year


Reata Pharmaceuticals Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $202.695. Pessimistic: $193.78. Optimistic: $218.10



Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 237.56 222.83 247.54 9.98
Mar 240.41 230.31 275.99 16.55
Mar 209.16 189.50 231.33 18.08
Apr 197.86 187.18 214.09 12.57
May 230.71 208.10 258.39 19.46
Jun 253.78 219.77 276.62 20.55
Jul 273.57 251.69 287.25 12.38
Aug 274.12 246.71 295.50 16.51
Sep 282.34 263.14 324.70 18.96
Oct 235.47 200.62 252.43 20.52
Nov 235.47 206.28 273.15 24.48
Dec 246.31 231.53 256.16 9.62

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 226.11 209.38 241.48 13.30
Mar 253.69 235.43 288.20 18.31
Mar 247.61 225.82 275.34 17.99
Apr 247.11 220.42 283.68 22.30
May 223.88 207.32 240.90 13.94
Jun 236.42 217.03 256.28 15.31
Jul 193.39 167.86 213.89 21.52
Aug 179.85 153.24 207.91 26.30
Sep 179.85 160.43 202.52 20.78
Oct 175.54 151.66 188.53 19.55
Nov 164.30 157.40 184.35 14.62
Dec 194.21 168.18 217.12 22.54

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 231.88 198.49 264.35 24.91
Mar 253.22 228.91 271.45 15.67
Mar 241.06 223.70 260.35 14.07
Apr 249.26 216.36 262.72 17.65
May 203.39 187.94 227.39 17.35
Jun 165.56 141.39 188.41 24.96
Jul 149.34 142.77 171.44 16.72
Aug 159.79 144.77 180.56 19.82
Sep 149.88 129.50 169.37 23.54
Oct 164.27 146.20 181.36 19.38
Nov 196.14 187.51 206.34 9.13
Dec 222.82 208.11 243.32 14.47

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 240.20 225.79 258.93 12.80
Mar 284.87 273.48 318.49 14.13
Mar 308.23 275.56 327.96 15.98
Apr 257.07 232.39 272.49 14.72
May 245.24 221.21 273.20 19.03
Jun 246.71 218.09 265.46 17.84
Jul 281.75 254.13 298.65 14.91
Aug 325.13 275.06 363.50 24.33
Sep 384.96 344.15 438.85 21.58
Oct 381.11 363.58 428.37 15.12
Nov 422.27 358.08 472.10 24.15
Dec 382.58 351.97 432.31 18.58

Reata Pharmaceuticals information and performance

Reata Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Reata Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RETA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Reata Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.